New program aims to cut HIV risk by fighting stigma for drug users
NCT ID NCT07541131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called LIFT to help people who inject drugs in Kyrgyzstan face less stigma and lower their risk of HIV. About 80 participants will join peer-led group sessions to build support and learn how to use HIV prevention services. The goal is to see if the program reduces stigma and increases use of HIV prevention tools like PrEP and medication for opioid use disorder.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Eligible PWID will meet the following inclusion criteria: 1. reports injecting drugs or using drugs with someone who was injecting in the past 12 months before enrollment, 2. is currently using illicit drugs (salts, synthetics, pharmaceuticals or opioids) including poly drug use, 3. ≥ 18 years old, 4. live in one of the two eligible districts 5. report no intentions to move from Bishkek in the next 18 months, 6. baseline rapid HIV test confirming HIV-negative status, and 7. agree to participate in all intervention and assessment activities. Eligible MMT Staff participants inclusion criteria: All clinical, administrative, and support staff at our two clinical MMT sites and implementation sites are eligible to participate. Inclusion criteria are: 1. ≥ 18 years old, 2. work in one of the eligible clinics, and 3. agree to participate in all intervention and assessment activities. Exclusion Criteria: * PWID Exclusion criteria are: 1. initiated injection drug use in the past 6 months, 2. report not currently using illicit drugs, 3. are \< 18 years old, 4. live outside the two eligible districts, 5. intend to move outside Bishkek in the next 18 months, 6. do not agree to participate in all community-level intervention activities (i.e., five peer-led group sessions, four survey assessments over 18 months), or are confirmed to be living with HIV by self-report or baseline rapid test. Note, to protect against unintended HIV status disclosure, PWID who are living with HIV (PWID-HIV) and who meet all other inclusion criteria will be given the option to participate in all study activities. However, PWID-HIV will not be included in our analytic sample of 68 PWID. Study staff will screen all potentially eligible PWID to confirm eligibility, schedule the baseline assessment, and confirmatory rapid HIV test before randomization, with an interviewer not affiliated with LIFT intervention activities.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Drug abuse illicit are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Public Foundation Den Sooluk Nuru
Bishkek, Kyrgyzstan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 6-hour online course change how nurses treat HIV patients?
- Can a CMV-Based vaccine teach the body to fight HIV?
- Can a tailored therapy ease stigma and boost mental health for young black and latino gay men?
- Can a culturally adapted workshop break the cycle of HIV stigma?
- Fighting stigma to stop HIV: a new counseling approach put to the test
- Cash for care: a simple incentive to keep HIV patients on track